Cancer cachexia is a complex multi‐organ catabolic syndrome that reduces mobility,
increases fatigue, decreases the efficiency of therapeutic strategies, diminishes the quality of …

Cancer cachexia is a paraneoplastic syndrome characterized by lean mass wasting (with or
without fat mass decrease), culminating in involuntary weight loss, which is the key clinical …

The cancer anorexia cachexia syndrome is a systemic metabolic disorder characterized by
the catabolism of stored nutrients in skeletal muscle and adipose tissue that is particularly …

Background Sarcopenia frequently occurs in metastatic cancer patients. Emerging evidence
has revealed that various secretory products from metastatic tumours can influence host …

Background Cancer cachexia is a syndrome that does not fully recover with nutritional
support and causes appetite loss and body weight loss. It worsens a patient's quality of life …

Background Cachexia is a paraneoplastic syndrome related with poor prognosis. The
tumour micro‐environment contributes to systemic inflammation and increased oxidative …

Background: Cachexia and sarcopenia are associated with poor survival after colorectal
cancer (CRC) diagnosis. Computed tomography (CT) can be used to measure aspects of …

Background Lung cancer is the primary cause of cancer deaths worldwide. Activation of
epidermal growth factor receptor (EGFR) leads to lung cancer progression and poor …

Background Breast cancer is one of the most commonly diagnosed cancers, and the fourth
leading cause of cancer deaths in females worldwide. Sarcopenia is related to adverse …

Mobility in advanced cancer patients is a major health care concern and is often lost in
advanced metastatic cancers. Erosion of mobility is a major component in determining …